Filter
1778
Filtered Results: 1778
Text search:
molecular
Featured
Recommendations
205
New Publications
331
Language
Document type
No document type
780
Guidelines
394
Studies & Reports
317
Manuals
103
Strategic & Response Plan
76
Fact sheets
53
Training Material
19
Situation Updates
17
Resource Platforms
9
Infographics
7
Videos
2
Brochures
1
Countries / Regions
India
95
Latin America and the Carribbean
70
Global
62
Brazil
61
Western and Central Europe
60
Africa
39
Eastern Europe
36
Germany
34
Kenya
30
Colombia
30
South Africa
28
Ethiopia
22
Tanzania
22
Peru
22
Argentina
20
West and Central Africa
20
Venezuela
20
Russia
18
East and Southern Africa
17
El Salvador
16
Paraguay
15
Uganda
14
Mozambique
14
South–East Asia Region
14
Sierra Leone
13
Bolivia
13
Nigeria
12
Malawi
12
Senegal
11
Philippines
11
Rwanda
11
Nepal
10
Angola
10
Asia
10
Congo, Democratic Republic of
9
Zambia
9
Ukraine
9
Ecuador
9
Chile
9
Liberia
8
Indonesia
8
Middle East and North Africa
8
Ghana
7
Bangladesh
7
Namibia
7
Spain
7
Zimbabwe
6
Syria
6
Myanmar / Burma
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Guinea-Bissau
4
USA
4
Cameroon
4
Haiti
4
Pakistan
4
Italy
4
Vietnam
4
France
4
Guinea
3
Burkina Faso
3
Lebanon
3
Cambodia
3
Benin
3
Eswatini/ Swaziland
3
Botswana
3
Uruguay
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Niger
2
Somalia
2
South Sudan
2
Iraq
2
Jordan
2
Turkey
2
Chad
2
Thailand
2
China
2
Mauritania
2
Dominican Republic
2
Honduras
2
Libya
2
Guatemala
2
Tajikistan
2
Georgia
2
North America
2
United Kingdom
2
Portugal
2
Morocco
1
Afghanistan
1
Egypt
1
Gambia
1
Malaysia
1
Sudan
1
North Macedonia
1
Switzerland
1
Cuba
1
Madagascar
1
Lesotho
1
Mexico
1
Nicaragua
1
Yemen
1
Palestine
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Qatar
1
Estonia
1
Romania
1
Kazakhstan
1
Turkmenistan
1
Japan
1
Tunisia
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
615
Clinical Guidelines
223
Public Health
76
Pharmacy & Technologies
65
Key Resources
29
Women & Child Health
23
Capacity Building
6
Toolboxes
TB
389
COVID-19
279
AMR
113
NTDs
111
HIV
86
Rapid Response
78
Mental Health
78
Ebola
46
Planetary Health
46
Zika
33
Pharmacy
31
NCDs
27
Refugee
21
Polio
14
Caregiver
14
Specific Hazards
11
Cholera
10
Global Health Education
9
Disability
8
Health Financing Toolbox
6
Conflict
5
Natural Hazards
4
This situation analysis has gathered information about the current state of AMR, contributing factors and antimicrobial use in Zimbabwe from the human, animal, agricultural and environmental sectors. Data has been gathered from different sectors such as the general public, academia, the Ministry of ...
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...
The global emergence of antimicrobial resistance (AMR) is posing a threat to human health. Putting resources into the containment of AMR – including surveillance – is one of the highest-yield investments a country can make to mitigate its impact. In 2015, WHO launched the Global Antimicrobial Re...
El informe anual de la vigilancia de la resistencia a los antibióticos de los países participantes de la Región de las Américas se discute y analiza con el fin de tomar medidas para el perfeccionamiento continuo de la calidad de los datos, y su utilidad en la orientación a los clínicos para el...
Antimicrobial resistant (AMR) organisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for HIV and the pathogens that cause malaria, tuberculosis, typhoid, cholera, meningitis...
Jin et al. Military Medical Research (2020) 7:4 https://doi.org/10.1186/s40779-020-0233-6
Position Article und Guideline
El uso de los antimicrobianos en seres humanos es imprescindible para combatir a los microorganismos causantes de distintas enfermedades, no obstante, el uso y abuso de estos productos farmacéuticos ha propiciado un aumento en la resistencia, desarrollo y propagación de microorganismos multirresis...
The objectives of NAP are aligned with the global action plan based on national needs and priorities. The emphasis is on One Health approach with all sectors especially human health, animal health and environment contributing towards minimizing the emergence and impact of AMR in Jordan.
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...
Antibiotics have been useful in fighting infectious diseases in our country for decades, but because of the overuse and misuse of these agents, an increasing number of organisms are now resistant to them. The Philippines, like other Southeast Asian countries, has already been encountering the many c...
Antimicrobials have been a critical public health tool since the discovery of penicillin in 1928, saving the lives of millions of people around the world. Today, however, the emergence of drug resistance is reversing the miracles of the past eighty years, with drug choices for the treatment of many ...
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing...
A Students' Toolkit.
How does the digital transformation of health care change the daily routine of a healthcare professional? Which knowledge and skills will healthcare professionals need? Are universities in Europe preparing their students well enough to work within a digitised health system?
Th...
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid antigen tests in different transmission scenarios of t...
Qualitative assay for use on the cobas®6800/8800 Systems. For in vitro diagnostic use
The role of environmental contamination in transmission of COVID-19 virus is currently not clear. This protocol has been designed to determine (viable) virus presence and persistence on fomites in various locations where a patient infected with COVID-19 is currently receiving care or being isolated,...
COVID Reference 2021.6 EN
recommended
6th edition 13 January 2021 CR 2021.6.10, uploaded on 27 May 2021
Find eight editions: Deutsch | English | Español | Français | Italiano | Português | Tiếng Việt | Türkçe
https://covidreference.com/download
6a edición clínica. Nuevo: 4. Vacunas (26 de abril); Nuevo: 5. Pruebas y procedimientos de diagnóstico (7 de abril); Nuevo: 7. COVID-19 persistente (7 de abril)
La 3ieme édition du nouveau mini-manuel.
Au cours des mois à venir COVID Reference publiera des mises à jour régulières.
